Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2023 Feb 25

PMID 36833173

Authors

Wiktor Bilecki

Marzena Mackowiak

Affiliations

Soon will be listed here.

Abstract

Schizophrenia pathogenesis remains challenging to define; however, there is strong evidence that the interaction of genetic and environmental factors causes the disorder. This paper focuses on transcriptional abnormalities in the prefrontal cortex (PFC), a key anatomical structure that determines functional outcomes in schizophrenia. This review summarises genetic and epigenetic data from human studies to understand the etiological and clinical heterogeneity of schizophrenia. Gene expression studies using microarray and sequencing technologies reported the aberrant transcription of numerous genes in the PFC in patients with schizophrenia. Altered gene expression in schizophrenia is related to several biological pathways and networks (synaptic function, neurotransmission, signalling, myelination, immune/inflammatory mechanisms, energy production and response to oxidative stress). Studies investigating mechanisms driving these transcriptional abnormalities focused on alternations in transcription factors, gene promoter elements, DNA methylation, posttranslational histone modifications or posttranscriptional regulation of gene expression mediated by non-coding RNAs.

Citing Articles

Neurostructural changes in schizophrenia and treatment-resistance: a narrative review.

Paul T, See J, Vijayakumar V, Njideaka-Kevin T, Loh H, Lee V Psychoradiology. 2024; 4:kkae015.

PMID: 39399446 PMC: 11467815. DOI: 10.1093/psyrad/kkae015.

Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations.

Clarin J, Bouras N, Gao W Genes (Basel). 2024; 15(9).

PMID: 39336805 PMC: 11431303. DOI: 10.3390/genes15091214.

Altered Expression of PDE4 Genes in Schizophrenia: Insights from a Brain and Blood Sample Meta-Analysis and iPSC-Derived Neurons.

Burrack N, Yitzhaky A, Mizrahi L, Wang M, Stern S, Hertzberg L Genes (Basel). 2024; 15(5).

PMID: 38790238 PMC: 11121586. DOI: 10.3390/genes15050609.

Temporal changes of gene expression in health, schizophrenia, bipolar disorder, and major depressive disorder.

Arakelyan A, Avagyan S, Kurnosov A, Mkrtchyan T, Mkrtchyan G, Zakharyan R Schizophrenia (Heidelb). 2024; 10(1):19.

PMID: 38368435 PMC: 10874418. DOI: 10.1038/s41537-024-00443-7.

TrkB-dependent regulation of molecular signaling across septal cell types.

Rodriguez L, Tran M, Garcia-Flores R, Oh S, Phillips 3rd R, Pattie E Transl Psychiatry. 2024; 14(1):52.

PMID: 38263132 PMC: 10805920. DOI: 10.1038/s41398-024-02758-6.

References

Selemon L, Zecevic N . Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl Psychiatry. 2015; 5:e623. PMC: 4564568. DOI: 10.1038/tp.2015.115. View

Lopez-Gonzalez I, Pinacho R, Vila E, Escanilla A, Ferrer I, Ramos B . Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia. Eur Neuropsychopharmacol. 2019; 29(3):384-396. DOI: 10.1016/j.euroneuro.2018.12.011. View

Purcell S, Moran J, Fromer M, Ruderfer D, Solovieff N, Roussos P . A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014; 506(7487):185-90. PMC: 4136494. DOI: 10.1038/nature12975. View

Kristiansen L, Beneyto M, Haroutunian V, Meador-Woodruff J . Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry. 2006; 11(8):737-47, 705. DOI: 10.1038/sj.mp.4001844. View

Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T . DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci. 2005; 25(22):5376-81. PMC: 6725011. DOI: 10.1523/JNEUROSCI.0766-05.2005. View

Kristiansen L, Huerta I, Beneyto M, Meador-Woodruff J . NMDA receptors and schizophrenia. Curr Opin Pharmacol. 2006; 7(1):48-55. DOI: 10.1016/j.coph.2006.08.013. View

Yonezawa K, Tani H, Nakajima S, Nagai N, Koizumi T, Miyazaki T . AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. Schizophr Res. 2022; 243:98-109. DOI: 10.1016/j.schres.2022.02.033. View

Paul A, Nawalpuri B, Shah D, Sateesh S, Muddashetty R, Clement J . Differential Regulation of Translation by FMRP Modulates eEF2 Mediated Response on NMDAR Activity. Front Mol Neurosci. 2019; 12:97. PMC: 6520660. DOI: 10.3389/fnmol.2019.00097. View

Lauriat T, Dracheva S, Chin B, Schmeidler J, McInnes L, Haroutunian V . Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience. 2005; 137(3):843-51. DOI: 10.1016/j.neuroscience.2005.10.003. View

10.

Ferguson B, Gao W . PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders. Front Neural Circuits. 2018; 12:37. PMC: 5964203. DOI: 10.3389/fncir.2018.00037. View

11.

Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L . Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008; 82(3):696-711. PMC: 2427301. DOI: 10.1016/j.ajhg.2008.01.008. View

12.

Hino M, Kunii Y, Matsumoto J, Wada A, Nagaoka A, Niwa S . Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia. J Psychiatr Res. 2016; 82:100-8. DOI: 10.1016/j.jpsychires.2016.07.018. View

13.

Rajarajan P, Jiang Y, Kassim B, Akbarian S . Chromosomal Conformations and Epigenomic Regulation in Schizophrenia. Prog Mol Biol Transl Sci. 2018; 157:21-40. PMC: 6318347. DOI: 10.1016/bs.pmbts.2017.11.022. View

14.

Fromer M, Pocklington A, Kavanagh D, Williams H, Dwyer S, Gormley P . De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014; 506(7487):179-84. PMC: 4237002. DOI: 10.1038/nature12929. View

15.

Volk D, Moroco A, Roman K, Edelson J, Lewis D . The Role of the Nuclear Factor-κB Transcriptional Complex in Cortical Immune Activation in Schizophrenia. Biol Psychiatry. 2018; 85(1):25-34. PMC: 6289758. DOI: 10.1016/j.biopsych.2018.06.015. View

16.

Iwamoto K, Bundo M, Ueda J, Oldham M, Ukai W, Hashimoto E . Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011; 21(5):688-96. PMC: 3083085. DOI: 10.1101/gr.112755.110. View

17.

Zhang L, Verwer R, Lucassen P, Huitinga I, Swaab D . Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide. J Psychiatr Res. 2019; 121:31-38. DOI: 10.1016/j.jpsychires.2019.11.002. View

18.

Arion D, Corradi J, Tang S, Datta D, Boothe F, He A . Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry. 2015; 20(11):1397-405. PMC: 4492919. DOI: 10.1038/mp.2014.171. View

19.

Dienel S, Lewis D . Alterations in cortical interneurons and cognitive function in schizophrenia. Neurobiol Dis. 2018; 131:104208. PMC: 6309598. DOI: 10.1016/j.nbd.2018.06.020. View

20.

Bauer D, Gupta D, Harotunian V, Meador-Woodruff J, McCullumsmith R . Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res. 2008; 104(1-3):108-20. PMC: 2656372. DOI: 10.1016/j.schres.2008.06.012. View